"Upregulation of PD-L1 was seen in 81% (n=17/21) o
Post# of 153169

From Figure 4, it seems many of the patients achieved Medium levels of PD-L1.
Yet only 25% of patients received ICI with or after leronlimab.
Sadly, it seems many others may have had an opportunity to overcome their disease had they been given ICI.

